 |
|
Reducing IV Admixture-Related Safety Risks: A Review of the ISMP Sterile Preparation Compounding Guidelines |
 |
|
Midday Symposia #5
Monday, December 3, 2012 — 11:30 AM – 1:30 PM
(Lunch will be provided)
North Convention Center, Room South Pacific J
Las Vegas, NV
|
REGISTRATION IS CLOSED
REGISTER BY THURSDAY
NOVEMBER 30, 2012
Space is limited and pre-registration is encouraged. Click here to register.
|
|
This symposium is funded through an educational grant from Baxter Corporation.
|  |
Program Overview |
|
|
Sterile compounding of IV products in hospitals is a top public health issue—there have been numerous reports of harmful and fatal errors, many involving infants or children. This symposium will review new guidelines developed through the Institute for Safe Medication Practices (ISMP) national invitational Sterile Preparation Compounding Safety Summit, held in October 2011.
Speakers will review current methods used to compound sterile products and identify the quality control practices that are necessary for preparing and verifying the safety of the final product. Existing and emerging technologies for creating IV admixtures, manual and automated safeguards to help ensure the correct product is dispensed, and barriers to best practices also will be discussed.
back to top |
|
Program Topics and Faculty |
Introduction and Program Overview
Michael R. Cohen, RPh, MS, ScD (hon), FASHP
President, ISMP
Why the ISMP Sterile Preparation Compounding Guidelines are Important
Eric Kastango, MBA, RPh, FASHP
Principal-CEO, Clinical IQ, LLC
Review of Guidelines from the ISMP Summit on Sterile Compounding Safety
Matthew Fricker, RPh, MS, FASHP
Program Director, ISMP
Federal and Professional Oversight of Compounding—Considerations for Risk-Benefit Decision Making
Eric Kastango, MBA, RPh, FASHP
Principal-CEO, Clinical IQ, LLC
back to top |
|
Objectives |
|
Following completion of this symposium, participants will be able to:
- Recognize the system-based causes of errors in the sterile compounding of IV products
- Review quality control measures used to ensure correct sterile product preparation
- Identify the minimum safeguards that must be in place to prepare and dispense compounded sterile products
- Describe role of current and emerging technologies that assist in sterile preparation
- Utilize recently developed ISMP guidelines on admixture safety to ensure safe preparation of compounded sterile products by pharmacies in acute care facilities
back to top |
|
Continuing Education |
|
Educational Review Systems is accredited by the Accreditation for Pharmaceutical Education as a provider of continuing pharmaceutical education and complies with the Criteria for Quality for continuing pharmaceutical education. The program is approved for 2.0 contact hours (0.20 CEUs). ACPE #0761-9999-12-148-L05-P.
back to top |
|
About ISMP
|
|
The Institute for Safe Medication Practices (ISMP) is the nation’s only nonprofit organization devoted entirely to medication error prevention and safe medication use. ISMP represents more than 35 years of experience in helping healthcare practitioners keep patients safe, and continues to lead efforts to improve the medication use process. For more information, visit www.ismp.org
back to top |
The Institute for Safe Medication Practices (ISMP)
200 Lakeside Drive, Suite 200, Horsham, PA 19044
www.ismp.org
Phone: (215) 947-7797
Fax: (215) 914-1492
If you are having problems with this message, please click here.
|
|
|
|
